Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Deciphering interactions between colorectal cancer risk factors
From the GECCO Coordinating Center, Public Health Sciences Division
The timing of aspirin use may improve survival time
From the Newcomb Lab, Public Health Sciences Division.
Aspirin and its cousins linked to longer survival after colorectal cancer
Large study of preventive drugs for colorectal cancer survivors finds link to decreased mortality — but only for those with certain tumor genetics
Fred Hutch study suggests NSAIDs improve survival for certain colorectal cancer patients
Findings published in Journal of Clinical Oncology show NSAID benefits associated with cancer subtype and timing of drug’s use
WHI analysis links NSAID use with lower colorectal cancer mortality
PHS presentation clarifies the importance of different durations of nonsteroidal, anti-inflammatory drug use on risk of dying from colorectal cancer
Anti-inflammatory drugs increase colon cancer survival
PHS researchers show 20 percent drop in mortality with prior NSAID use
Migraines lower breast cancer risk
New study by Christopher Li confirms his landmark research linking migraines with reduced risk of breast cancer
Aspirin significantly reduces esophageal-cancer risk in people with most-aggressive form of Barrett's esophagus
Study also identifies biomarkers that predict which patients are most likely to get cancer